id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-292611-5os99sve	Lopes, Renato D.	Anticoagulation in COVID-19: It Is Time for High-Quality Evidence	2020-10-20		.txt	text/plain	221	26	26	key: cord-292611-5os99sve cord_uid: 5os99sve There are many challenges to conducting randomized controlled trials, especially in the face of a pandemic, but they are necessary to determine whether and how treatments affect outcomes. Pulmonary embolism in patients with COVID-19: awareness of an increased prevalence Evidence-based practical guidance for the antithrombotic management in patients with coronavirus disease (COVID-19) in 2020 COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC State-ofthe-Art Review Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19 Randomized trials versus common sense and clinical observation: JACC Review Topic of the Week Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients Heparin thromboprophylaxis in medical-surgical critically ill patients: a systematic review and meta-analysis of randomized trials American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients COVID-19, randomized controlled trials JACC	./cache/cord-292611-5os99sve.txt	./txt/cord-292611-5os99sve.txt